Selected research
Industry Research
Digital Therapeutics (DTx) For Mental Health Industry Research Report 2026
Market perspective
The global Digital Therapeutics (DTx) For Mental Health market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Therapeutics (DTx) For Mental Health market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Therapeutics (DTx) For Mental Health market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Therapeutics (DTx) For Mental Health market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Therapeutics (DTx) For Mental Health include WellDoc, Pear Therapeutics, COGNIFIT, Ginger, Propeller Health, 2morrow, Canary Health, Noom and Teladoc Health and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Therapeutics (DTx) For Mental Health market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Therapeutics (DTx) For Mental Health.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Therapeutics (DTx) For Mental Health Market by Company
WellDoc
Pear Therapeutics
COGNIFIT
Ginger
Propeller Health
2morrow
Canary Health
Noom
Teladoc Health
Omada Health
Digital Therapeutics (DTx) For Mental Health Segment by Type
Biology Modifying Drugs
Gene Therapies
Cell Therapies
Digital Therapeutics (DTx) For Mental Health Segment by Application
Pharmaceutical Companies
Academic and Research Institutions
Others
Digital Therapeutics (DTx) For Mental Health Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics (DTx) For Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics (DTx) For Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics (DTx) For Mental Health.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Therapeutics (DTx) For Mental Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Biology Modifying Drugs
- Gene Therapies
- Cell Therapies
Applications
- Pharmaceutical Companies
- Academic and Research Institutions
- Others
Companies covered
- WellDoc
- Pear Therapeutics
- COGNIFIT
- Ginger
- Propeller Health
- 2morrow
- Canary Health
- Noom
- Teladoc Health
- Omada Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Therapeutics (DTx) For Mental Health by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Biology Modifying Drugs
- 2.2.3 Gene Therapies
- 2.2.4 Cell Therapies
- 2.3 Digital Therapeutics (DTx) For Mental Health by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Companies
- 2.3.3 Academic and Research Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Digital Therapeutics (DTx) For Mental Health Breakdown Data by Type
- 3.1 Global Digital Therapeutics (DTx) For Mental Health Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Therapeutics (DTx) For Mental Health Forecasted Market Size by Type (2027-2032)
4 Digital Therapeutics (DTx) For Mental Health Breakdown Data by Application
- 4.1 Global Digital Therapeutics (DTx) For Mental Health Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Therapeutics (DTx) For Mental Health Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Therapeutics (DTx) For Mental Health Market Perspective (2021-2032)
- 5.2 Global Digital Therapeutics (DTx) For Mental Health Growth Trends by Region
- 5.2.1 Global Digital Therapeutics (DTx) For Mental Health Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Therapeutics (DTx) For Mental Health Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Therapeutics (DTx) For Mental Health Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Therapeutics (DTx) For Mental Health Market Dynamics
- 5.3.1 Digital Therapeutics (DTx) For Mental Health Industry Trends
- 5.3.2 Digital Therapeutics (DTx) For Mental Health Market Drivers
- 5.3.3 Digital Therapeutics (DTx) For Mental Health Market Challenges
- 5.3.4 Digital Therapeutics (DTx) For Mental Health Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Therapeutics (DTx) For Mental Health Players by Revenue
- 6.1.1 Global Top Digital Therapeutics (DTx) For Mental Health Players by Revenue (2021-2026)
- 6.1.2 Global Digital Therapeutics (DTx) For Mental Health Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Therapeutics (DTx) For Mental Health Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Therapeutics (DTx) For Mental Health Head Office and Area Served
- 6.4 Global Digital Therapeutics (DTx) For Mental Health Players, Product Type & Application
- 6.5 Global Digital Therapeutics (DTx) For Mental Health Manufacturers Established Date
- 6.6 Global Digital Therapeutics (DTx) For Mental Health Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
- 7.2 North America Digital Therapeutics (DTx) For Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 7.4 North America Digital Therapeutics (DTx) For Mental Health Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
- 8.2 Europe Digital Therapeutics (DTx) For Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 8.4 Europe Digital Therapeutics (DTx) For Mental Health Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Therapeutics (DTx) For Mental Health Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
- 10.2 South America Digital Therapeutics (DTx) For Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 10.4 South America Digital Therapeutics (DTx) For Mental Health Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Therapeutics (DTx) For Mental Health Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 WellDoc
- 12.1.1 WellDoc Company Information
- 12.1.2 WellDoc Business Overview
- 12.1.3 WellDoc Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.1.4 WellDoc Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.1.5 WellDoc Recent Developments
- 12.2 Pear Therapeutics
- 12.2.1 Pear Therapeutics Company Information
- 12.2.2 Pear Therapeutics Business Overview
- 12.2.3 Pear Therapeutics Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.2.4 Pear Therapeutics Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.2.5 Pear Therapeutics Recent Developments
- 12.3 COGNIFIT
- 12.3.1 COGNIFIT Company Information
- 12.3.2 COGNIFIT Business Overview
- 12.3.3 COGNIFIT Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.3.4 COGNIFIT Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.3.5 COGNIFIT Recent Developments
- 12.4 Ginger
- 12.4.1 Ginger Company Information
- 12.4.2 Ginger Business Overview
- 12.4.3 Ginger Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.4.4 Ginger Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.4.5 Ginger Recent Developments
- 12.5 Propeller Health
- 12.5.1 Propeller Health Company Information
- 12.5.2 Propeller Health Business Overview
- 12.5.3 Propeller Health Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.5.4 Propeller Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.5.5 Propeller Health Recent Developments
- 12.6 2morrow
- 12.6.1 2morrow Company Information
- 12.6.2 2morrow Business Overview
- 12.6.3 2morrow Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.6.4 2morrow Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.6.5 2morrow Recent Developments
- 12.7 Canary Health
- 12.7.1 Canary Health Company Information
- 12.7.2 Canary Health Business Overview
- 12.7.3 Canary Health Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.7.4 Canary Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.7.5 Canary Health Recent Developments
- 12.8 Noom
- 12.8.1 Noom Company Information
- 12.8.2 Noom Business Overview
- 12.8.3 Noom Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.8.4 Noom Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.8.5 Noom Recent Developments
- 12.9 Teladoc Health
- 12.9.1 Teladoc Health Company Information
- 12.9.2 Teladoc Health Business Overview
- 12.9.3 Teladoc Health Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.9.4 Teladoc Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.9.5 Teladoc Health Recent Developments
- 12.10 Omada Health
- 12.10.1 Omada Health Company Information
- 12.10.2 Omada Health Business Overview
- 12.10.3 Omada Health Revenue in Digital Therapeutics (DTx) For Mental Health Business (2021-2026)
- 12.10.4 Omada Health Digital Therapeutics (DTx) For Mental Health Product Portfolio
- 12.10.5 Omada Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst